EGRP Cancer Epidemiology News
EGRP Cancer Epidemiology News is a monthly e-newsletter with information regarding funding opportunities related to cancer epidemiology, grantsmanship issues, research resources, and other relevant news.
Featured News Articles
Cannabis Use Among Cancer Survivors
September 2024
Learn about results from surveys conducted on cannabis use among cancer survivors at 12 NCI-Designated Cancer Centers, active NIH notices of funding opportunities related to cannabis use and cancer, and additional resources related to research on cannabis and cannabinoid use in adult cancer patients.
Continue ReadingNCI Funding Opportunities to Foster Research Independence for Early Career Investigators
August 2024
Several NCI funding opportunities are now available to senior postdoctoral fellows or faculty-level candidates. These K awards aim to support research career development, including a mentored research scientist development award for early career researchers working in cancer control and population sciences.
Continue ReadingEnabling Large-Scale Data Collaborations
July 2024
NCI's Epidemiology and Genomics Research Program supports a number of resources for facilitating research across the cancer control continuum, including the NCI Cohort Consortium and the Cancer Epidemiology Descriptive Cohort Database.
Continue ReadingDr. Erin Siegel Named Associate Director of NCI’s Epidemiology and Genomics Research Program (EGRP)
June 2024
Dr. Erin Siegel has been named Associate Director of EGRP in the National Cancer Institute's (NCI) Division of Cancer Control and Population Sciences (DCCPS). EGRP is the largest funder of cancer epidemiologic research worldwide; its focus is to support research in human populations to understand determinants of cancer occurrence and outcomes.
Continue ReadingResearch Highlights
EGRP Research Highlights
Each year, the Epidemiology and Genomics Research Program publishes a Research Highlights list to showcase a selection of recent publications resulting from research projects in the EGRP grant portfolio.
View the 2023 Research Highlights